Health Care & Life Sciences » Pharmaceuticals | Grape King Bio Ltd.

Grape King Bio Ltd. | Income Statement

Fiscal year is January-December. All values TWD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
5,652
6,283
7,248
9,185
9,388
9,183
Cost of Goods Sold (COGS) incl. D&A
695
771
924
1,347
1,615
1,967
Gross Income
4,957
5,512
6,323
7,838
7,773
7,216
SG&A Expense
3,612
3,912
4,511
5,604
5,519
4,866
EBIT
1,345
1,600
1,812
2,234
2,254
2,350
Unusual Expense
3
-
1
-
-
-
Non Operating Income/Expense
77
87
91
107
164
83
Interest Expense
-
-
23
32
18
14
Pretax Income
1,427
1,689
1,883
2,312
2,405
2,427
Income Tax
246
303
336
426
471
537
Consolidated Net Income
1,181
1,387
1,547
1,887
1,935
1,890
Net Income
836
942
1,052
1,297
1,352
1,295
Net Income After Extraordinaries
836
942
1,052
1,297
1,352
1,295
Net Income Available to Common
836
942
1,052
1,297
1,352
1,295
EPS (Basic)
6.42
7.24
8.07
9.82
10.03
9.57
Basic Shares Outstanding
130
130
130
132
135
135
EPS (Diluted)
6.42
7.20
7.94
9.57
9.93
9.50
Diluted Shares Outstanding
130
131
133
137
137
137
EBITDA
1,468
1,727
1,963
2,443
2,479
2,606
Non-Operating Interest Income
2
2
3
3
5
7
Minority Interest Expense
346
444
495
590
583
595

About Grape King Bio

View Profile
Address
No. 402, Section 2 Jinling Road
Taoyuan 324
Taiwan
Employees -
Website http://www.grapeking.com.tw
Updated 07/08/2019
Grape King Bio Ltd. engages in the manufacture and sale of health food products. It focuses on the mushroom mycelium and probiotics. Its business activities include preparation of pharmaceutical products, medicines, and raw materials; as well as the manufacture and trade of medical equipment.